BTIG Maintains Buy on CeriBell, Raises Price Target to $30

Benzinga Newsdesk www.benzinga.com Positive 80.1%

Neg 0% Neu 0% Pos 80.1%

BTIG analyst Marie Thibault maintains CeriBell (NASDAQ:CBLL) with a Buy and raises the price target from $28 to $30.

Comments

No comments yet. Be the first!